Skip to main content
. 2005 Jan 28;333(1):180–189. doi: 10.1016/j.virol.2005.01.002

Fig. 2.

Fig. 2

Activation of JNK pathway. (A) Mock-treated or Tula virus-infected cell lysates were resolved in SDS–PAGE and transferred onto nitrocellulose, the membranes were then treated (on the right) or untreated with CIP. (B) TULV-infected or mock Vero E6 cell lysates were collected at the indicated day p.i. and analyzed with antibodies against c-jun (rabbit monoclonal and rabbit polyclonal). Infection was monitored with antibody against nucleocapsid protein. β-actin was used as a loading control. (C) JNK inhibitor II SP600126 (50 μM, added every other day) blocked the cleavage of PARP in Vero E6 cells on the fifth day post-Tula virus infection.